FAS and neoplasm: Tumor-expressed markers, such as programmed death ligand 1 (PD-L1) [29], inhibit both the T-cell and NK cell response, whereas downregulation of Fas and tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) dampens lymphocyte-mediated tumor cell apoptosis [30].